Identification of symbol digit modality test score extremes in Huntington's disease.


Journal

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
ISSN: 1552-485X
Titre abrégé: Am J Med Genet B Neuropsychiatr Genet
Pays: United States
ID NLM: 101235742

Informations de publication

Date de publication:
04 2019
Historique:
received: 24 04 2018
revised: 14 12 2018
accepted: 08 02 2019
pubmed: 23 2 2019
medline: 18 4 2020
entrez: 22 2 2019
Statut: ppublish

Résumé

Studying individuals with extreme phenotypes could facilitate the understanding of disease modification by genetic or environmental factors. Our aim was to identify Huntington's disease (HD) patients with extreme symbol digit modality test (SDMT) scores. We first examined in HD the contribution of cognitive measures of the Unified Huntington's Disease Rating Scale (UHDRS) in predicting clinical endpoints. The language-independent SDMT was used to identify patients performing very well or very poorly relative to their CAG and age cohort. We used data from REGISTRY and COHORT observational study participants (5,603 HD participants with CAG repeats above 39 with 13,868 visits) and of 1,006 healthy volunteers (with 2,241 visits), included to identify natural aging and education effects on cognitive measures. Separate Cox proportional hazards models with CAG, age at study entry, education, sex, UHDRS total motor score and cognitive (SDMT, verbal fluency, Stroop tests) scores as covariates were used to predict clinical endpoints. Quantile regression for longitudinal language-independent SDMT data was used for boundary (2.5% and 97.5% quantiles) estimation and extreme score analyses stratified by age, education, and CAG repeat length. Ten percent of HD participants had an extreme SDMT phenotype for at least one visit. In contrast, only about 3% of participants were consistent SDMT extremes at two or more visits. The thresholds for the one-visit and two-visit extremes can be used to classify existing and new individuals. The identification of these phenotype extremes can be useful in the search for disease modifiers.

Identifiants

pubmed: 30788902
doi: 10.1002/ajmg.b.32719
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

232-245

Subventions

Organisme : Medical Research Council
ID : MR/M008592/1
Pays : United Kingdom
Organisme : European Commission
ID : 305444
Pays : International

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Ulrike Braisch (U)

Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.

Rainer Muche (R)

Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.

Dietrich Rothenbacher (D)

Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.

Georg Bernhard Landwehrmeyer (GB)

Department of Neurology, Ulm University, Ulm, Germany.

Jeffrey D Long (JD)

Department of Psychiatry, University of Iowa, Iowa City, Iowa.
Department of Biostatistics, University of Iowa, Iowa City, Iowa.

Michael Orth (M)

Department of Neurology, Ulm University, Ulm, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH